The test measures two proteins that are linked to amyloid plaques in the brain, which are among the hallmarks of Alzheimer's.

The new test, known as the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, detects amyloid plaques through blood testing, a ...

Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...

A new study published in the Neurology and Urodynamics journal reveals that long-term use of anticholinergic drugs, commonly ...

While Alzheimer's disease is mostly considered a disorder of the brain, emerging evidence suggests that the condition also affects other organs of the body. Working with the laboratory fruit fly, ...

The FDA has approved the first blood test to help detect Alzheimer’s disease. Developed by Fujirebio Diagnostics, the ...

The FDA said the results of the newly cleared blood test must be assessed in conjunction with other clinical information from ...

The first-ever blood test to detect Alzheimer’s disease has been cleared by the U.S. Food and Drug Administration (FDA). In a ...

The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment ...

The US on Friday approved the first blood test for Alzheimer's, a move that can help patients begin treatment earlier with ...

Dr Kellyn Lee is a chartered psychologist at the University of Southampton who has spent years studying this debilitating ...

Sex-based differences in microglia could help explain patterns in brain diseases. For example, Alzheimer’s affects more women ...